AAAAAA
Results:
1-16
|
Results: 16
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)
Authors:
Scheja, A
Akesson, A
Geborek, P
Wildt, M
Wollheim, CB
Wollheim, FA
Vischer, UM
Citation: A. Scheja et al., Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma), ARTHRITIS R, 3(3), 2001, pp. 178-NIL_1
Authors:
Roux-Lombard, P
Eberhardt, K
Saxne, T
Dayer, JM
Wollheim, FA
Citation: P. Roux-lombard et al., Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation inearly rheumatoid arthritis. A prospective 5-year study, RHEUMATOLOG, 40(5), 2001, pp. 544-551
Authors:
Wollheim, FA
Citation: Fa. Wollheim, Enteropathic arthritis: how do the joints talk with the gut?, CURR OP RH, 13(4), 2001, pp. 305-309
Authors:
Wollheim, FA
Citation: Fa. Wollheim, Approaches to rheumatoid arthritis in 2000, CURR OP RH, 13(3), 2001, pp. 193-201
Authors:
Castro, F
Acevedo, E
Ciusani, E
Angulo, JA
Wollheim, FA
Sandberg-Wollheim, M
Citation: F. Castro et al., Tumour necrosis factor microsatellites and HLA-DRB1, HLA-DQA1*, and HLA-DQB1*alleles in Peruvian patients with rheumatoid arthritis, ANN RHEUM D, 60(8), 2001, pp. 791-795
Authors:
Geirsson, AJ
Wollheim, FA
Akesson, A
Citation: Aj. Geirsson et al., Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale, ANN RHEUM D, 60(12), 2001, pp. 1117-1122
Authors:
Wollheim, FA
Citation: Fa. Wollheim, Selective Cox-2 inhibition in man - therapeutic breakthrough or cosmetic advance?, RHEUMATOLOG, 39(9), 2000, pp. 935-938
Authors:
Scheja, A
Wildt, M
Wollheim, FA
Akesson, A
Saxne, T
Citation: A. Scheja et al., Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement, RHEUMATOLOG, 39(10), 2000, pp. 1110-1113
Authors:
Wollheim, FA
Citation: Fa. Wollheim, Markers of disease in rheumatoid arthritis, CURR OP RH, 12(3), 2000, pp. 200-204
Authors:
Wollheim, FA
Citation: Fa. Wollheim, The prevalence of rheumatoid arthritis in Sweden, SC J RHEUM, 29(3), 2000, pp. 204-204
Authors:
Wollheim, FA
Citation: Fa. Wollheim, Bone sialoprotein - a new marker for subchondral bone, OSTEO CART, 7(3), 1999, pp. 331-332
Authors:
Wollheim, FA
Citation: Fa. Wollheim, Serum markers of articular cartilage damage and repair, RHEUM DIS C, 25(2), 1999, pp. 417
Authors:
Wollheim, FA
Citation: Fa. Wollheim, A humble gentleman at 100 - Henrik Sjogren, CLIN EXP RH, 17(6), 1999, pp. 648
Authors:
Medsger, TA
Silman, AJ
Steen, VD
Black, CM
Akesson, A
Bacon, PA
Harris, CA
Jablonska, S
Jayson, MIV
Jimenez, SA
Krieg, T
Leroy, EC
Maddison, PJ
Russell, ML
Schachter, RK
Wollheim, FA
Zacharaie, H
Citation: Ta. Medsger et al., A disease severity scale for systemic sclerosis: Development and testing, J RHEUMATOL, 26(10), 1999, pp. 2159-2167
Authors:
Wollheim, FA
Citation: Fa. Wollheim, Scandinavia and the bone and joint decade 2000-2010 - A timely initiative, SC J RHEUM, 28(5), 1999, pp. 267-268
Authors:
Wollheim, FA
Citation: Fa. Wollheim, Should limited funds be directed at patient care or research?, CHALLENGES IN RHEUMATOID ARTHRITIS, 1999, pp. 300-310
Risultati:
1-16
|